These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings - United Therapeutics (NASDAQ:UTHR)

United Therapeutics Corp (NASDAQ:UTHR) reported better-than-expected earnings for the fourth quarter on Wednesday.The company posted quarterly earnings of $7.70 per share which beat the analyst consensus estimate of $7.09 per share. The company reported quarterly sales of $790.200 million which missed the analyst consensus estimate of $813.077 million.“As we close out another remarkable year with record total revenue for the fourth year in a row, I extend my thanks to our Unitherians whose unwavering commit ...